Just a moment, the page is loading...
Login Register
 
♥

Advanced Wound Management

Smith+Nephew's Advanced Wound Management portfolio provides comprehensive solutions to meet broad and complex clinical needs and to help healthcare professionals reduce the human and economic consequences of wounds. These include products for the treatment of acute and chronic wounds such as leg, diabetic and pressure ulcers, burns, and post-operative wounds.

To be considered for financial support in the next calendar year all applications must be submitted by May 31st. If your application is successful, funding will be confirmed by Q4 of the current calendar year at the latest.

If you wish to discuss your proposal prior to submission please send an email to studyrequest@smith-nephew.com in the email please include your contact details, details of your institution and a brief summary of your planned activity, including the Smith & Nephew product of interest.

To submit a proposal, navigate to the appropriate study type at the bottom of the page and click the ‘Submit Proposal’ button within. For support during the submission process please use the ‘Contact Us’ box on the Home page.

Submit Idea
View All Selected
Clear All

Smith+Nephew recognizes the importance of supporting Clinical Activities that lead to a greater understanding of our therapies and their potential applications, improved patient care, and new ideas for further research.

We accept unsolicited requests for research grants from academic and community-based clinician-scientists who are interested in conducting their own activity. Please click areas of interest to see what our current evidence needs are.

To be considered for financial support in the next calendar year all applications must be submitted by May 31st.

All investigators who are awarded support must provide Smith+Nephew with ongoing study updates and final deliverables.

We welcome proposals for a variety of clinical activities including Investigator Initiated Studies (IISs), Manuscript/Abstract Preparation activities and Collaborative Clinical Research projects and activities. Click the tiles at the bottom of this page to learn more about each and proceed with proposal submission.

As the sponsor of the study, the investigator and/or institution assume responsibility for all aspects of the study.

  • Study design and protocol development
  • Institutional and regulatory approvals and reporting
    • IRB/EC approval
    • Registration on ClinicalTrials.gov
    • IND/IDE application submission
    • Serious adverse event reporting to the FDA, IRB, and Smith+Nephew
  • Study conduct in accordance with ICH GCP Guidelines and all applicable local and regulatory requirements
  • Communication of all ongoing study updates (see section below)
  • Reconciliation and closeout reporting (see section below)
  • Clinical study report submission within 90 days of study completion
  • Dissemination of study results in a peer-reviewed publication and/or at a medical meeting within 6 months of study completion

The Investigator needs to complete a study proposal and budget, these will be provided once you have selected the relevant study type below.

Researchers are invited to submit their concept proposal using this Smith+Nephew submission portal via the 'Submit Proposal' button found on each study types page - found by first navigating to a Product type page. Each submission will be reviewed collectively by the Smith+Nephew Review Committee based on scientific merit and alignment with corporate research, key business objectives and development plans.

Support is awarded based upon scientific merit, as well as alignment with our research areas of interest and availability of resources. We may provide support in the form of funding, and/or study product.

Once submitted, a review of your proposal will take place including initial proposal and budget review, before moving on to an in-depth departmental review.

The Investigator should not commence work on a proposal until a fully executed contract is in place. All contracts are with the Institution not the Investigator.

Smith+Nephew will provide all or partial funding for any Study that has been approved, it may also be possible for Smith+Nephew to provide the product(s) required directly, upon request. Investigators can not be paid directly. All funding is to the institution responsible for and housing the patient data.

The Investigator must notify Smith+Nephew of the following updates for ongoing studies:

  • Amendments to the study protocol
  • Regulatory re-approvals
  • Serious adverse events reports
  • Achievement of study milestones related to milestone payments
  • Subject enrollment progress (e.g., first subject in, last subject in, last subject out, etc.)

This can be done via the ‘Follow-up forms’ tab within your submitted proposal in the ‘My Submissions’ area.

A clinical study report (CSR) is required within 90 days of study completion. The CSR should be written in accordance with the ICH Guidance for Structure and Content of Clinical Study Reports. Please refer to our guidance document here. A CSR template is provided for you here.

All publications should comply with recognized ethical standards concerning publications and authorship, including the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, established by the International Committee of Medical Journal Editors.

Smith+Nephew may request to be able to review the results at least 30 days in advance of submission for publication. For research support that includes funding, the final milestone payment is dependent on submission for publication or presentation of study results.

Benefits to you: Funding support for research interests, Opportunities to collaborate with peers by participating in multi-center S&N sponsored studies and Med Ed opportunities to attend advanced courses/conferences

Benefits to S+N: Evidence to guide strategic direction for the life of the product, Clinical data to support product claims & meet regulatory requirements

PRESSURE Injury Prevention

Total Solutions - LEAF◊ + ALLEVYN◊ or LEAF◊ + ALLEVYN◊ + SKIN CARE
Pressure Injury Prevention in at Risk Populations - ICU, OR, ER, Pediatrics/Neonates, Palliative/End of Life Care

PICO

Closed Incision

Reduction of surgical site complications in high-risk patient groups -v- standard of care - including health economic outcomes in routine practice, as part of a surgical protocol

Current specialties of interest include:
  • C-Section
  • Orthopedic (Hip and Knee)
  • Oncoplastic Breast Surgery
  • Cardiac
Stalled Wounds
Use of PICO (with or without any S&N product) to manage stalled/chronic wound types to accelerate healing outcomes across all care settings.
  • Venous Leg Ulcers (under compression, of any type)
  • Diabetic Foot Ulcers
  • Dehisced Surgical Wounds
  • Pressure Ulcers/Injuries
Use of PICO in deeper wounds (with filler) on any wound indication

RENASYS◊ tNPWT System

  • Use of the RENASYS system in complex case management
  • Use of RENASYS system as part of an acute discharge pathway
  • Ease of use with RENASYS Soft Port (e.g., to avoid bridging, minimize complications, and reduce application complexity)
  • Impact of adopting RENASYS system (with or without transition to PICO) on clinical outcomes and healthcare resource utilization versus previous practice
  • Use of RENASYS system and PICO to treat open wounds as part of a pathway approach (i.e., healing outcomes, simplicity, time to discharge, and impact on operational efficacy)
Use of RENASYS system with ACTICOAT (and any other S+N products) to manage infected wounds

AWB

  • SANTYL wound and economic outcomes
  • SANTYL use before CAMPS, Impact of SANTYL on hospital readmissions

AWT

  • GRAFIX efficacy in plastics and reconstructive surgery, and chronic wounds
  • OASIS efficacy in burns and abdominal wounds
  • STRAVIX efficacy in plastics and reconstructive surgery. general, urology and traumatic surgery and complex wounds

Pressure Injury Prevention

  • ALLEVYN LIFE◊
  • SKIN CARE
  • Total Solutions - LEAF◊ + ALLEVYN◊ or LEAF◊ + ALLEVYN◊ + SKIN CARE
  • Pressure Injury Prevention in at Risk Populations - ICU, OR, ER, Pediatrics/Neonates, Palliative/End of Life Care

Prevention of Surgical Site Complications

  • PICO◊
Reduction of surgical site complications in high risk patient groups -v- standard of care – including health economic outcomes
Improving clinical and economic outcomes in chronic wounds

Negative Pressure Wound Therapy

  • PICO◊
    Improvement in wound healing and patient-related outcomes, including health economic outcomes, compared to standard care within the following wound types – DFU, VLU, Open Surgical Wounds, PU
  • RENASYS◊
    • Use of the RENASYS NPWT system in complex case management
    • Use of RENASYS NPWT as part of an acute discharge pathway
    • Use of RENASYS and PICO to treatment open wounds as part of a pathway approach

    Click HERE for detailed Request for Proposal information on RENASYS

Antimicrobials 

  • ACTICOAT◊ - in acute wounds (burns and trauma) and in chronic wound management (PU, VLU, DFU)
  • IODOSORB◊ - in chronic wound management (PU, VLU, DFU)

Exudate Management

  • Use of ALLEYVN Life◊ in hospital across variety of wounds
  • Use of ALLEVYN◊ portfolio for exudate management in acute and community settings
  • Use of ALLEVYN◊ portfolio for exudate management as part of a shared care approach


The following study types may be considered for support: 

  • Prospective or Retrospective clinical studies involving Smith+Nephew products 
  • Non-interventional research, such as epidemiology or outcomes studies, where the focus is on scientific understanding of the disease 

We do not provide support for the following: 

  • Proposals that are not aligned with our current areas of interest 
  • Proposals that are conditioned upon past or future prescriptions or purchases of Smith+Nephew products 
  • Requests that create a conflict of interest for Smith+Nephew 


  • Investigator Initiated Studies

    A clinical study designed and initiated by an investigator, whereby S+N provide funding (monetary or medical devices) but do not act as Sponsor. Any type of study design (qualitative/quantitative) can be an IIS as the design of the study and proposal submitted to S+N for consideration comes directly from the Investigator/HCP.
    Read More

  • Collaborative Clinical Research

    A clinical activity whereby the design and/or conduct of said activity is done jointly to collaborate on fulfilling the objectives of the activity.




    Read More

  • Manuscript/Abstract Preparation

    Any type of clinical research whereby an investigator/HCP approaches S+N to ask for assistance (monetary or resource) to analyse and/or write up their existing data (external to S+N) for publication or as a conference proceeding.


    Read More

  • Real World Evidence
     

    The collection or extraction of data from routine patient treatment, that is available within the patient medical record (paper or EMR) or at the time treatment/procedure.





    Read More
We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential.
The content on this website may not be approved for use in your specific region or country. Smith+Nephew is not responsible for any interactions or dealings you have via this website that do not comply with applicable laws and regulations in your jurisdiction. By continuing to use this website, you acknowledge and agree the terms of this notice.
◊Trademark of Smith+Nephew. Product information is for educational purposes only, and not all products or indications are licensed in every country.